Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Benton Susan, Director. Insider active across 2 companies, notably Ocuphire Pharma, Inc.. Aggregated, 16 filings have been logged. Split: 2 buys · 0 sell. Total volume traded: €154k. Activity tracked since 2 September 2021. The latest transaction was filed on 30 April 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Susan Benton is a Director at Ocuphire Pharma, Inc. In this role, she participates in the governance of the company and strategic decision-making. Benton brings valuable expertise to the board through her experience in the pharmaceutical sector. Her commitment to innovation and corporate responsibility is essential in guiding Ocuphire's initiatives. She collaborates with other board members to ensure the strategic direction of the company.